Delivery Order SPE2DB22D3016-SPE2DB25FBHP6
Award Date 9/8/25
Potential Completion Date 9/29/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $4,085.52 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg VEKLURY (Remdesivir) vials. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a federal contract worth up to $1,361.84 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,361 to Amerisourcebergen Drug Corporation. The order is for 4561486616 units of Veklury 100mg vials to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 3, 2023. Veklury is the brand name for remdesivir, an antiviral medication used to treat certain patients hospitalized with COVID-19. As a major provider of pharmaceuticals and medical supplies to the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The delivery order is valued at $13,618.40 and has a completion date of April 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Veklury (Remdesivir) 100 mg vials. The contract, valued at $2,042.76, is a delivery order with a firm fixed price and an ultimate completion date of October 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply the critical COVID-19 treatment drug to support military treatment facilities and other federal...
- This federal contract award is for the delivery of VEKLURY (Remdesivir) 100 mg vials to the Defense Logistics Agency (DLA). The $2,113.38 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024 with a completion date of December 27, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- The Defense Logistics Agency awarded a $15,848.80 delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, with an ultimate completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...